Skip to Content

About Us

Appointments & Memberships

Current Titles/Affiliations

Primary Appointments

  • President, The University of Texas MD Anderson Cancer Center
  • Professor of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Dual/Joint Appointment

  • Member, graduate faculty, The University of Texas Graduate School of Biomedical Sciences at Houston

Academic Appointments

  • Assistant professor of medicine, University of California, San Diego, 1970-74
  • Associate professor of medicine, University of California, San Diego, 1974-79
  • Consultant lecturer, Naval Regional Medical Center, San Diego, 1974-85
  • Consultant lecturer, Camp Pendleton, Calif., 1974-85
  • Professor of medicine, University of California, San Diego, 1979-85
  • Member, Memorial Sloan-Kettering Cancer Center, New York, 1985-96
  • Member, Program of Molecular Pharmacology and Therapeutics, Sloan-Kettering Institute for Cancer Research, New York, 1985-96
  • Attending physician, New York Hospital, New York, 1985-96
  • Visiting physician, Rockefeller University Hospital, New York, 1985-96
  • Consulting staff, Department of Medicine, North Shore University Hospital, Manhasset, N.Y., 1985-96
  • Professor of Medicine, The University of Texas MD Anderson Cancer Center, 1996-present
  • Member, graduate faculty, The University of Texas Graduate School of Biomedical Sciences at Houston, 1998-present

Academic Administrative Appointments/Responsibilities

  • Co-head, Division of Hematology/Oncology (Oncology), University of California, San Diego, 1976-85
  • Founding director of cancer center, University of California, San Diego, 1976-85
  • Co-chairman, Program of Molecular Pharmacology and Therapeutics, Sloan-Kettering Institute for Cancer Research, New York, 1985-1990
  • Professor and cice-chairman, Department of Medicine, Cornell University Medical College, New York, 1985-96
  • Attending physician and chairman, Department of Medicine, Memorial Hospital, New York, 1985-96
  • President, The University of Texas MD Anderson Cancer Center, 1996-present

MD Anderson Committee Activities

Current

  • Member, Audit Committee
  • Member, Clinical Council
  • Chair, Compensation Leadership Committee
  • Chair, Facilities Steering Committee
  • Member, Information Systems Steering Committee
  • Chair, Institutional Compliance Committee
  • Ex-officio, Institutional Review Board (Surveillance Committee)
  • Member, Leadership Forum
  • Chair, Management Committee
  • Chair, President’s Advisory Board
  • Ex-officio, Research Council
  • Chair, University Cancer Foundation Administrative Board
  • Member, DOD Prostate Cancer Consortium Advisory Board

Prior

  • Member, External Advisory Committee for Research, MD Anderson Cancer Center, 1995-96

Other Appointments/Responsibilities

  • Member, Cancer Advisory Council of the State of California, 1979-85
  • Member, Board of Directors, American Cancer Society, San Diego Branch, 1981-85
  • Member, Advisory Committee, National Flow Cytometry Resource at Los Alamos National Laboratory, 1982-85
  • Chairman, Cancer Therapeutics Program Projects Study Section, NCI-NIH Grants Review Branch, 1982-85
  • Member, Oncology Advisory Board, Schering Corporation, 1985-86
  • Member, Biological Response Modifiers Program Decision Network Committee, 1986-87
  • Member, Division of Cancer Treatment Board of Scientific Counselors, 1986-90
  • Member, Leukemia Society of America’s Grant Review Subcommittee, 1987-90
  • Member, Oncology Advisory Board, Genentech Inc., 1987
  • Member, Oncology Advisory Board, Hoffmann-LaRoche, 1987-89
  • Member, Scientific Advisory Board, Lineberger Cancer Center, University of North Carolina, 1987-89
  • Member, The Century Association, 1987
    • Member, Membership Committee, 1996
  • Member, Scientific Advisory Board, Institute for Molecular Pathology, Vienna, 1988-91
  • Member, External Review Committee, Division of Oncology, Stanford University Medical Center, 1988-91
  • Member, Board of Scientific Counselors, Division of Cancer Treatment, National Cancer Institute, 1989-92
  • Member, Scientific Advisory Committee, Immunex, 1990-92
  • Member, Board of Directors, American Association for Cancer Research (elected), 1990-93
  • Member, Advisory Committee, University of Wisconsin Comprehensive Cancer Center, 1990-93
  • Member, Scientific Advisory Committee, Bristol-Myers Squibb, 1990-2002
  • Member, Scientific Advisory Board, ImClone Systems Inc., New York, 1992-2002
  • Member, Task Force for an NIH Strategic Plan, 1992
  • Member, Scientific Advisory Board, NCI-EORTC Symposia on New Drugs in Cancer Therapy, 1992-present
  • Member, International Congress on Anticancer Chemotherapy Advisory Board, 1992-present
  • Chairman, Johns Hopkins Oncology Center External Advisory Board, 1993-present
  • Member, Advisory Board, Selective Genetics Inc. (formerly Prizm Inc.), 1993-present
  • Member, Advisory Board, Abbott Biotech, Inc., 1994-95
  • Member, Imperial Cancer Research Fund Scientific Advisory Committee, 1994-present
  • Scientific Advisor for Cancer Research, Pfizer, 1995
  • Member, Board of Directors, Richard Lounsbery Foundation, 1995-2000
  • Member, Scientific Advisory Board, Progenics Pharmaceuticals Inc., 1995-present
  • Member, Scientific Advisory Board, Merck Institute, 1995-2000
  • Member, General Motors Cancer Research Foundation Awards Assembly, 1995-97
  • Chairman, External Advisory Committee, Washington University Cancer Center, 1996-98
  • Member, Advisory Committee for the Rotary Lombardi Award, 1996
  • Member, Houston Grand Opera Board of Trustees, 1996
  • Member, Rotary Club of Houston, 1996-present
  • Member, Board of Scientific Counselors for Intramural Research Programs, National Cancer Institute, 1997-2001
  • Member, Board of Governors, The Houston Forum, 1997-99
  • Member, Institute of Medicine, National Academy of Sciences, 1996-present
  • Member, National Cancer Policy Board-1999-2002
  • Member, Institute of Medicine and Division of Earth and Life Sciences’ Committee on Large-Scale Science and Cancer Research, 2002-2003
  • Member, Executive Committee, Greater Houston Partnership, 1997
    • Member, Business Issues Advisory Committee, 2000-2002
    • Member, Board of Directors, 1997-2003
    • Member, Health Services Steering Committee, 2000-present
    • Member, Strategic Planning Committee, 2005
  • Member, Board of Directors, Houston Technology Center, 1998-present
  • Member, Board of Directors, ImClone Systems Incorporated, 1998-2003
  • Member, Executive Committee, The Houston Forum, 1998-present
  • Member, Science Division of the Royal Netherlands Academy of Arts and Sciences, 1998-present
  • Member, Scientific Committee and International Advisory Board, 9th International Congress on Anti-Cancer Treatment, 1999-present
  • Member, Board of Directors, Enron Corporation, 1999-2002
  • Member, Scientific Advisory Board, Thyreos Corporation, 1999-2003
  • Member, U.S. House of Representatives Taskforce to Reevaluate Medicare Reimbursements for Training Doctors at Teaching Hospitals (Headed by Congressman Nick Lampson), 1999-2000
  • Member, Board of Directors, Center for Houston’s Future, 2000-2007
  • Member, National Dialogue on Cancer, 1996-present
  • Member, Team on Cancer Research, 2001
  • Member, External Advisory Committee, University of California San Diego Cancer Center, 1999-present
  • Member, Electorate Nominating Committee of the Section on Medical Sciences, American Association for the Advancement of Science, 2001-2004
  • Member, Advisory Board, Harvard Medical School, 2001-present
  • Member, Medical Advisory Task Force, The Baker Institute
  • Member, Board of Directors and Vice Chairman, BioHouston, 2001-present
  • Member, Governor’s Council on Science and Biotechnology Development, 2002-present
  • Member, Scientific Advisory Committee, Biotherapy Development Association, Cancer Research UK, 2003-present
  • Member, Singapore’s Biomedical Sciences International Advisory Council, September 2003-present
  • Member, Centro Nacional de Investigaciones Oncologicas(CNIO) Scientific Advisory Board, Madrid, Spain, 2003-present
  • Co-Chairperson, AACR 2004 Clinical Research Awards Committee (Selection Committee), 2004
  • Member, AACR 2004-2005 Nominating Committee for the Clinical Research and Experimental Therapeutics Awards, 2004-present
  • Honorary Trustee, Board of Trustees for the Gulf Coast Regional Blood Center, 1997-present
  • Member, ASCO Roster of Cancer Experts, Cancer Communication Committee, 2005-present
  • President, Institut Gustave-Roussy Scientific Council, 2005-present
  • Consultant, Texas Medical Association, 2004-present
  • Vice Chair, Agency for Science, Technology and Research Advisory Committee, 2005-present
  • Member, Advisory Committee for the Holocaust Museum Houston’s 2007 exhibit, 2006-present
  • Member, The Leadership Council of the President’s Circle, AACR Foundation for the Prevention and Cure of Cancer, 2006-present
  • Chair, Cancer Center Directors — Working Group, 2006-present
  • Honorary Committee Member, American Hospital of Paris 100th Anniversary Gala, 2006
  • Member, Board of Directors, Association of American Cancer Institutes (AACI), 2006-present
  • Member, Board of Directors, Texas Institute for Genomic Medicine, 2006-present
  • Member, Finance Committee, The Academy of Medicine, Engineering and Science of Texas, 2007-present
  • Member, Scientific Advisory Board, Targeted Molecular Diagnostics, 2007-2011
  • Member, National Cancer Policy Forum, Institute of Medicine, Improving the Quality of Cancer Clinical Trials Workshop, 2007
  • Chair, Planning Committee for Cooperative Groups (subcommittee of the forum), 2007
  • Member, Scientific Advisory Board, American-Italian Cancer Foundation, 2008-
  • Member, Scientific Advisory Board, National Center for Tumor-Disease, Germany, 2008-
  • Member, Institute of Medicine, National Cancer Policy Forum, 2008-2011
  • Member, International Advisory Board of King Hussein Institute for Biotechnology and Cancer, 2008
  • Member, Board of Advisors of the Bilateral US Arab Chamber of Commerce, 2008
  • Member, Philosophical Society of Texas, 2008-
  • Member, Junior Achievement of Southeast Texas Inc., 2009
  • Member, Founding Board of the iHealth Trust, 2010
  • Chair, Worldwide Innovative Networking in Personalized Cancer Medicine Association, 2010-

Consultantships

  • Texas Medical Association, Council on Medical Education, 1996-present

Editorial/Review Activities

  • Founding Editor-in-Chief, Clinical Cancer Research, 1994-2004
  • Editor/Service on Editorial Boards
  • Editorial Board, Journal of Immunology, 1979-83
  • Editorial Board, Blood, 1983-87
  • Editorial Board, Journal of Clinical Oncology, 1985-89
  • Associate Editor, Cancer Research, 1986-95
  • Editorial Board, Growth Factors, 1988-98
  • Editorial Board, Journal of Biological Response Modifiers, 1990-98
  • Founding Editor-in-Chief, Clinical Cancer Research, 1994-2005
  • Editorial Board, Expert Review of Anticancer Therapy, 2000-present
  • Editorial Board, Molecular Oncology, 2006-present

Professional Memberships/Activities

Local/State

  • Texas Medical Association, Texas
  • Harris County Medical Society, Texas

National/International

  • American College of Physicians
  • American Society of Hematology
    • Chairman, Scientific Subcommittee on Neoplasia, 1997
  • American Association of Immunologists
  • American Association for Cancer Research
    • Chairman, Nominating Committee, 1987-89
    • Public Affairs Committee, 1988-89
    • Board of Directors, 1990-93
    • Chairman, Publications Committee, 1991-94
    • Finance Committee, 1991-94
    • Founding Editor-in-Chief, Clinical Cancer Research, 1994-present
  • American Society for Clinical Investigation
  • American Society of Clinical Oncology
    • Chairman, Program Committee, 1987
    • Chair, Molecular Oncology Committee, 2000-2001
  • Association of American Physicians
  • Harvey Society
  • American Clinical and Climatological Association
  • The Practitioners Society of New York
  • New York Academy of Medicine
  • American Medical Association
  • The Century Association
    • Membership Committee

Leave a Message for John Mendelsohn, M.D.

Through his visionary leadership of 
MD Anderson since 1996, John Mendelsohn, M.D., has made significant impacts in cancer research, patient care, education and prevention.

As he prepares to step down as president and return to clinical and translational research as co-director of the new Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, we encourage you to leave a message for him.

Mendelsohn Tributes

Anne and John Mendelsohn, M.D., have had a tremendous impact on MD Anderson over the past 15 years.


© 2011 The University of Texas MD Anderson Cancer Center